Log In
Print
BCIQ
Print
Print this Print this
 

Sustiva, efavirenz (DMP 266)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor; Antiviral agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat AIDS; Treat HIV infection/AIDS
Regulatory Designation

Partner

Bristol-Myers Squibb Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today